VPA 985, an orally active vasopressin receptor antagonist improves hyponatremia in patients with cirrhosis - a double blind placebo controlled multicenter trial (Abstract). - Gerbes,A.L.; Guelberg,V.; Decaux,G.; Gross,P.; Massien,C. (Hepatology, 1999)